Topics

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 19, Status: Authorised

06:48 EDT 11 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 19, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 19, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): DuoPlavin, clopidogrel / acetylsalicylic acid, Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 14/03/2010, Revision: 19, Status: Authorised"

Quick Search

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...